Trials / Terminated
TerminatedNCT02346643
A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG stimulatiOn in the Nordic Region
BINGO: A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG stimulatiOn in the Nordic Region
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 41 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
11-SMI-2013 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of intractable, chronic pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantation with the commercially available Axium Neurostimulator |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-01-27
- Last updated
- 2019-02-04
- Results posted
- 2018-02-19
Locations
2 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02346643. Inclusion in this directory is not an endorsement.